More recently, Cappetta and colleagues showed that DPP-4 inhibition might reduce the progression of DN by suppressing the inflammatory mediators, such as TNF-α, IL-1β, IL-6, and MCP-1 in rats [57], suggesting a potential immunomodulatory effect for these drugs. This evidence concerns the gene TNF and liver dysplastic nodule.